loading
전일 마감가:
$127.42
열려 있는:
$127.33
하루 거래량:
2.71M
Relative Volume:
0.46
시가총액:
$220.99B
수익:
$41.95B
순이익/손실:
$13.40B
주가수익비율:
16.55
EPS:
7.65
순현금흐름:
$6.35B
1주 성능:
-2.37%
1개월 성능:
-4.78%
6개월 성능:
+11.53%
1년 성능:
+13.73%
1일 변동 폭
Value
$126.49
$127.76
1주일 범위
Value
$124.50
$128.62
52주 변동 폭
Value
$99.71
$140.84

애보트 래버러토리스 Stock (ABT) Company Profile

Name
명칭
Abbott Laboratories
Name
전화
(224) 667-6100
Name
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
직원
114,000
Name
트위터
@AbbottNews
Name
다음 수익 날짜
2025-01-22
Name
최신 SEC 제출 서류
Name
ABT's Discussions on Twitter

ABT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
ABT
Abbott Laboratories
126.64 220.99B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
101.34 148.66B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
374.04 144.26B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
91.12 115.99B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
70.72 41.68B 5.72B 4.17B 259.90M 6.97

애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-08 개시 Oppenheimer Outperform
2024-09-19 개시 Piper Sandler Overweight
2024-07-30 다운그레이드 Edward Jones Buy → Hold
2024-05-30 개시 Goldman Buy
2023-07-21 업그레이드 Wolfe Research Underperform → Peer Perform
2023-05-30 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2023-04-20 재확인 Barclays Overweight
2023-04-20 재확인 Bernstein Outperform
2023-04-20 재확인 JP Morgan Overweight
2023-04-20 재확인 Raymond James Outperform
2023-04-20 재확인 UBS Buy
2023-04-20 재확인 Wolfe Research Underperform
2023-03-29 개시 UBS Buy
2022-10-26 개시 Mizuho Neutral
2022-10-18 개시 Barclays Overweight
2022-10-12 개시 Jefferies Hold
2022-07-06 개시 Wolfe Research Underperform
2022-03-02 재개 BofA Securities Buy
2022-01-27 재확인 Credit Suisse Outperform
2022-01-27 재확인 Morgan Stanley Overweight
2022-01-27 재확인 Raymond James Outperform
2022-01-27 재확인 UBS Buy
2021-12-10 개시 RBC Capital Mkts Outperform
2021-10-27 업그레이드 Atlantic Equities Neutral → Overweight
2021-10-14 개시 Redburn Neutral
2021-05-25 개시 Barclays Overweight
2021-04-15 개시 Atlantic Equities Neutral
2021-01-28 업그레이드 BTIG Research Neutral → Buy
2020-09-11 개시 Wolfe Research Outperform
2020-06-01 다운그레이드 Goldman Neutral → Sell
2020-03-05 개시 Citigroup Buy
2020-02-13 개시 Goldman Neutral
2020-02-06 재개 BTIG Research Neutral
2020-01-02 다운그레이드 Guggenheim Buy → Neutral
2019-06-13 재확인 BofA/Merrill Buy
2019-02-07 재확인 BofA/Merrill Buy
2019-01-02 다운그레이드 Citigroup Neutral → Sell
2018-11-30 업그레이드 Goldman Neutral → Buy
2018-10-16 개시 Barclays Overweight
2018-06-27 개시 Bernstein Outperform
2018-01-30 재확인 Citigroup Neutral
2018-01-25 재확인 Stifel Buy
2018-01-25 업그레이드 William Blair Mkt Perform → Outperform
2018-01-03 개시 Evercore ISI Outperform
2018-01-02 업그레이드 JP Morgan Neutral → Overweight
2018-01-02 업그레이드 Morgan Stanley Equal-Weight → Overweight
2017-10-19 재확인 RBC Capital Mkts Outperform
2017-10-19 재확인 Stifel Buy
모두보기

애보트 래버러토리스 주식(ABT)의 최신 뉴스

pulisher
11:30 AM

What Does the Market Think About Abbott Laboratories? - Benzinga

11:30 AM
pulisher
07:44 AM

Abbott’s world-first portable whole blood rapid test for concussions launches in the UK (2) - PharmiWeb.com

07:44 AM
pulisher
06:09 AM

U.S. Clinical Nutrition Market Is Booming Worldwide 2025-2032 | - openPR

06:09 AM
pulisher
Mar 19, 2025

Medtronic, Abbott Block Boston Scientific Heart Valve IP - Law360

Mar 19, 2025
pulisher
Mar 19, 2025

Abbott launches portable concussion blood test in UK - Medical Device Network

Mar 19, 2025
pulisher
Mar 19, 2025

Abbott Laboratories: An Insight Into Its Medtech & Diagnostic Growth Trajectory & Why It May Not Be Enough To Warrant A ‘Buy’ Rating! - Smartkarma

Mar 19, 2025
pulisher
Mar 19, 2025

Brazil Enteral Nutrition Market Is Booming Worldwide 2025-2032 - openPR

Mar 19, 2025
pulisher
Mar 19, 2025

Medical Nutrition Market Key Players Analysis- Abbott - openPR

Mar 19, 2025
pulisher
Mar 18, 2025

RFK Jr.’s Next Targets Are Companies Making Baby Formula - Yahoo Finance

Mar 18, 2025
pulisher
Mar 18, 2025

US health agencies announce plan to strengthen infant formula supply and quality -March 18, 2025 at 02:23 pm EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Abbott Laboratories (ABT): Among the Best Diabetes Stocks to Buy According to Billionaires - Insider Monkey

Mar 18, 2025
pulisher
Mar 18, 2025

Decoding Abbott Laboratories's Options Activity: What's the Big Picture? - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views? - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Personalized Vitamins Market Top Players- BASF SE, Abbott Laboratories. Amway Corporation, Bayer AG, Caligenix. - openPR

Mar 18, 2025
pulisher
Mar 17, 2025

Abbott's Narrow Economic Moat Rests on a Solid Product Portfolio - Morningstar

Mar 17, 2025
pulisher
Mar 17, 2025

Abbott Laboratories Gains 12.7% in a Year: What's Driving the Stock? - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

Blood Typing Analysis Report 2024: Market Set to Surge to $6.50 Billion by 2034, PCR and Microarray Techniques Pave the Way - GlobeNewswire Inc.

Mar 17, 2025
pulisher
Mar 17, 2025

Abbott Stock Could Be On The Verge Of A Breakout — Here’s What Smart Money Sees (NYSE:ABT) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 17, 2025

Reckitt’s Mead Johnson, Abbott to face new trial in US infant-formula case - just-food.com

Mar 17, 2025
pulisher
Mar 17, 2025

Abbott Laboratories Insiders Sell US$3.3m Of Stock, Possibly Signalling Caution - Yahoo Finance

Mar 17, 2025
pulisher
Mar 16, 2025

Abbott Laboratories' (NYSE:ABT) earnings growth rate lags the 15% CAGR delivered to shareholders - Simply Wall St

Mar 16, 2025
pulisher
Mar 16, 2025

Abbott Laboratories Basking In A Sharp Turn In Sentiment (NYSE:ABT) - Seeking Alpha

Mar 16, 2025
pulisher
Mar 15, 2025

Why Abbott Laboratories (ABT) Went Down On Thursday? - MSN

Mar 15, 2025
pulisher
Mar 15, 2025

Why Abbott Laboratories (ABT) Went Down On Friday? - Insider Monkey

Mar 15, 2025
pulisher
Mar 14, 2025

Abbott Labs, Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case - The Wall Street Journal

Mar 14, 2025
pulisher
Mar 14, 2025

Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial - Investopedia

Mar 14, 2025
pulisher
Mar 14, 2025

In a setback for Abbott Laboratories, judge allows new trial in case over formula for premature infants - Chicago Tribune

Mar 14, 2025
pulisher
Mar 14, 2025

Judge Vacates Baby Formula Trial Win For Abbott, Mead - Law360

Mar 14, 2025
pulisher
Mar 14, 2025

‘A Manifest Injustice': Judge Who Sanctioned Abbott’s Counsel Grants New Infant Formula Trial - Law.com

Mar 14, 2025
pulisher
Mar 14, 2025

Sector Update: Health Care -March 14, 2025 at 03:29 pm EDT - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

BofA keeps $150 target on Abbott Labs stock amid retrial news - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

Abbott, Reckitt Fall as Judge Grants New Trial on Infant Formula - Bloomberg

Mar 14, 2025
pulisher
Mar 14, 2025

Abbott, Reckitt face new trial over premature infant formula - Reuters

Mar 14, 2025
pulisher
Mar 14, 2025

That baby formula trial Abbott and Reckitt won isn't over just yet - Crain's Chicago Business

Mar 14, 2025
pulisher
Mar 14, 2025

Judge orders retrial in Abbott, Reckitt infant formula case - Seeking Alpha

Mar 14, 2025
pulisher
Mar 14, 2025

Citi maintains Abbott stock Buy rating, $160 target amid legal updates By Investing.com - Investing.com South Africa

Mar 14, 2025
pulisher
Mar 14, 2025

Is Abbott Laboratories (ABT) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey

Mar 14, 2025
pulisher
Mar 14, 2025

Citi maintains Abbott stock Buy rating, $160 target amid legal updates - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

Abbott, Reckitt face new trial over premature infant formula -March 14, 2025 at 11:09 am EDT - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

Positive Long-Term Outlook for Abbott Laboratories Despite Short-Term NEC Litigation Risks - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

Abbott sends film crew to highlight partnership with Auburn Community Hospital - The Citizen

Mar 14, 2025
pulisher
Mar 14, 2025

Abbott stock falls following retrial order in infant formula case - Investing.com

Mar 14, 2025
pulisher
Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025
pulisher
Mar 13, 2025

Abbott (ABT) Stock Moves -0.3%: What You Should Know - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - MSN

Mar 13, 2025
pulisher
Mar 12, 2025

Abbott (ABT) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Glucose Biosensor Market Booming with Technological Advancements | Industry Insights Abbott Laboratories, - EIN News

Mar 12, 2025
pulisher
Mar 12, 2025

Here's Why We Think Abbott Laboratories (NYSE:ABT) Might Deserve Your Attention Today - Yahoo Finance

Mar 12, 2025
pulisher
Mar 11, 2025

OTC Consumer Health Market Positioned for Accelerated Growth with Johnson&Johnson, Abbott Laboratories, - EIN News

Mar 11, 2025
pulisher
Mar 11, 2025

EPD Expansion Supports Abbot Stock, Macro Issues Prevail - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Neurological Biomarkers: Global Market Review 2020-2024 and - GlobeNewswire

Mar 11, 2025

애보트 래버러토리스 (ABT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_devices BSX
$101.28
price up icon 0.47%
medical_devices SYK
$373.91
price down icon 1.21%
medical_devices MDT
$91.28
price down icon 0.64%
medical_devices EW
$70.65
price down icon 0.28%
$82.22
price down icon 0.39%
자본화:     |  볼륨(24시간):